Cytosorbents Investor Relations Material
Latest events
Q3 2024
Cytosorbents
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Cytosorbents Corporation
Access all reports
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. The Company's business strategy is to develop its novel platform technology that enables it to manufacture and sell a broad range of products used in hemodialysis services, emergency medicine, surgery and clinics.
The Company’s clinical trials are focused on expanding applications for cytotoxic drugs such as chemotherapy for cancer patients as well as immune cell therapies for autoimmune diseases such as endocrine disorders, infectious disease and immunodeficiencies; regenerative medicine; organ preservation prior to transplantation; tissue repair grafting; acute care stabilization procedures allowing time for surgical interventions; and drug discovery applications for target validation, screening of potential new agents or natural compounds from plants or marine sources.
Key slides for Cytosorbents Corporation
Investor Presentation
Cytosorbents Corporation
Investor Presentation
Cytosorbents Corporation
Latest articles
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Anthony Noto: The Multifaceted CEO of SoFi
Anthony Noto built a successful and diverse career across multiple industries before becoming CEO of the fintech company SoFi.
9 Dec 2024
Ticker symbol
CTSO
Country
🇺🇸 United States